Email this article Efficacy and tolerance of stepwise therapy withmovalis in rheumatic diseases
- Authors: Tsvetkova ES1
-
Affiliations:
- Issue: Vol 79, No 12 (2004)
- Pages: 78-81
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/29975
- ID: 29975
Cite item
Full Text
Abstract
Keywords
References
- Wallace G. L. Nonsteroidal anti-inflammatory drugs and gastoenteropathy: the second hundred years. Gastroenterology 1997; 112: 1000-1016.
- Malmberg А. В., Yaksh T. L. Antinociceptive actions of spinalnonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther. 1992; 263: 136-146.
- Tilley S. L., Coffman T. M., Roller В. М. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 2001; 108: 15- 23.
- Vane G. R., Bakchle Y. S., Bolting R. M. Cyclooxygenase 1 and 2. Annu. Rev. Pharmacol. Toxicol. 1998; 38: 97-120.
- Насонов Е. Л., Цветкова Е. С. Селективные ингибиторы циклооксигеназы-2: новые перспективы лечения заболеваний человека. Тер. арх. 1998; 5: 8-14.
- Насонов Е. Л. Нестероидные противовоспалительные препараты (перспективы применения в медицине). М.; 2000.
- Needleman P., Isakson P. The discovery and function of COX-J. Rheumatol. 1997; 24(49): 6-8.
- Del Tacca M., Colucci R., Fornati M., Blandizzi С. Efficacy and tolerability of Meloxicam: nonsteroidal anti-inflammatory drug - selective inhibitor of a cyclooxygenase-2. Clin. Drug Invest. 2002; 22 (12): 799-818.
- Davies N. M., Skjodt N. M. Clinical pharmacokinetics of moxicam: a cyclooxygenase-2 preferential nonsteroidal antiflammatory drug. Clin. Pharmacokinet. 1999; 36: 115-126.
- Lapicque F., Vergne P., Gouzcau J.-I. et al. Articular diffusi of Meloxicam after a single oral dose: relationship to cycloc ygenaze inhibition in synovial cells. Clin. Pharmacokin 2000; 39: 369-382.
- Cacace L. Elevated serum CPK after drug injections. N. En J. Med. 1972;287:309-310.
- Combe В., Velicitat P., Garson N. et al. Comparison of intimuscular and oral meloxicam in rheumatoid arthritis patien Inflamm. Res. 2001; 50 (1): S10-S16.
- Auvinet В., Ziller R., Appelboom T. et al. Comparison of tonset and intensity of action of intramuscular Meloxicam aioral Meloxicam in patients with acute sciatica. Clin. The 1995; 17 (6): 78-90.
- Ghozlan P., Benhardt M., Velicitat P. et al. Tolerability of mutiple administration of intramuscular Meloxicam: a comparisc with of intramuscular Piroxicam in patients with rheumato arthritis or osteoarthritis. Br. J. Rheumatol. 1996; 35 (1): 51- 55.
Supplementary files
